Dr. Lepor becomes first urologist in the Northeast to perform the newly authorized Sonablate prostate tissue ablation procedure.

CHARLOTTE, N.C., JANUARY 26, 2016 -- SonaCare Medical, LLC announces that Drs. Herbert Lepor and James Wysock performed a HIFU Sonablate prostate tissue ablation procedure in New York City last week, making them the first physicians to use the device in the Northeast since Sonablate® received FDA clearance in October 2015.

Dr. Peretsman launches his U.S.-based prostate High Intensity Focused Ultrasound (HIFU) program in Huntersville, North Carolina by performing two HIFU procedures on the same day.

CHARLOTTE, N.C., JANUARY 13, 2016 -- SonaCare Medical, LLC announces the completion of two Sonablate® prostate tissue ablations performed by Dr. Samuel Peretsman. Both procedures were completed on Friday January 8th, 2016.

Physicians across the United States are adopting Sonablate® as the preferred prostate tissue ablation device.

CHARLOTTE, N.C., January 5, 2016 -- SonaCare Medical, LLC, a pioneer in minimally invasive high intensity focused ultrasound (HIFU) technologies, and first to receive FDA regulatory authorization for the ablation of prostate tissue, reports impressive Q4 growth in 2015 since receiving a de novo grant from the Food and Drug Administration (FDA) to market and sell Sonablate® in the United States in October, 2015.

SonaCare Medical HIFU device, Sonablate®, used by both Dr. Tracy Gapin and Dr. Stephen Scionti in Sarasota

CHARLOTTE, N.C., DECEMBER 17, 2015 - SonaCare Medical, LLC, industry leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, is pleased to report that Dr. Tracy Gapin has begun delivering prostate ablations at the Sarasota Interventional Radiology Treatment Center (SIR). Dr. Gapin performed his first U.S. Sonablate® procedure at SIR earlier this week, on December 15th, with guidance from Stephen Scionti, MD.

SonaCare Medical's HIFU device is used by Dr. Kar in first Sonablate® procedure at the miVIP Surgery Center, the fifth location in the United States to perform a HIFU prostate tissue ablation with Sonablate post FDA clearance

Charlotte, NC (PRWEB) December 15, 2015 -- SonaCare Medical, LLC, the leading manufacturer of urologic HIFU technology and the first to receive FDA regulatory authorization for the ablation of prostate tissue, has announced the fifth location in the United States to perform a Sonablate® procedure post FDA clearance. The miVIP Surgery Center, in Tustin, California, installed Sonablate® in mid-November and its leading physician, Dr. Ashok Kar, performed the center’s first U.S.-based prostate tissue ablation procedure this past weekend on December 12th.

Sonablate® continues to gain momentum as the preferred prostate tissue ablation device in the United States

CHARLOTTE, N.C., December 11, 2015 -- SonaCare Medical, LLC announces that Dr. Inderbir Gill performed two Sonablate® prostate tissue ablation procedures yesterday, December 10th, at Keck Medicine of USC. With the launch of University of Southern California's urologic HIFU program, Keck Medicine of USC becomes the first academic medical center in the United States to provide this pioneering technology since the FDA granted Sonablate® de novo clearance this past October for the ablation of prostate tissue.

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

10 April 2018

Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.

05 April 2018

CHARLOTTE, NC (PR NEWSWIRE) APRIL 05, 2018 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the enrollment of over 100 patients from...